Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Stopped Study was stopped 04.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of 10 patients planned) and CRC patients recruitment was stopped

Conditions

• Hepatocellular Cancer
• Non-small Cell Lung Cancer
• Renal Cell Cancer
• Colorectal Cancer

Interventions

• DRUG: Avastin
• DRUG: Suntent
• DRUG: Nexavar

Sponsor

Medical University Innsbruck